$SSSS
SURO CAPITAL CORP. Stock $ssss

$ssss Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223016116 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	-$3.805M	-$4.222M	$583.1K
YoY Change	-527.26%	-824.02%	101.07%
Cost Of Revenue	$1.214M	$1.213M	$1.201M
YoY Change	-1.02%	1.04%	140.16%
Gross Profit	$158.0K	$85.79K	-$617.7K
YoY Change	-146.99%	-113.89%	194.14%
Gross Profit Margin			-105.93%
Selling, General & Admin	$3.287M	$3.818M	$3.296M
YoY Change	8.29%	15.83%	38.49%
% of Gross Profit	2081.0%	4450.32%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$5.178M	$5.521M	$3.607M
YoY Change	49.01%	53.06%	37.15%
Operating Profit	-$5.020M	-$5.435M	-$4.225M
YoY Change	31.72%	28.65%	48.76%
Interest Expense	$1.214M	$1.213M	$24.68M
YoY Change	-101.34%	-95.08%	-77.73%
% of Operating Profit
Other Income/Expense, Net	$676.4K	$489.6K	$311.0K
YoY Change	53.89%	57.44%
Pretax Income	-$15.62M	$4.617M	$20.46M
YoY Change	-83.44%	-77.43%	-81.06%
Income Tax	$90.83K	$529.8K	$2.050K
% Of Pretax Income		11.48%	0.01%
Net Earnings	-$15.62M	$4.617M	$20.46M
YoY Change	-83.44%	-77.43%	-81.06%
Net Earnings / Revenue			3508.23%
Basic Earnings Per Share	-$0.60	$0.16	$0.66
Diluted Earnings Per Share	-$0.60	$0.16	$655.1K
COMMON SHARES
Basic Shares Outstanding	25.34M shares	28.34M shares	31.23M shares
Diluted Shares Outstanding	25.95M shares	28.38M shares	31.23M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.54M	$48.11M	$172.8M
YoY Change	-83.96%	-72.16%	4.31%
Cash & Equivalents	$24.54M	$48.11M	$172.8M
Short-Term Investments
Other Short-Term Assets	$485.2K	$654.2K	$790.2K
YoY Change	-17.56%	-17.21%	-12.2%
Inventory
Prepaid Expenses
Receivables	$119.6K	$105.0K	$87.82K
Other Receivables	$1.040M	$609.7K	$4.578M
Total Short-Term Assets	$26.19M	$49.48M	$178.3M
YoY Change	-83.19%	-72.25%	6.44%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$236.2M	$241.1M	$280.8M
YoY Change	18.05%	-14.14%	1.8%
Other Assets	$590.4K	$539.1K	$606.6K
YoY Change	0.11%	-11.13%	102.2%
Total Long-Term Assets	$236.8M	$241.6M	$281.4M
YoY Change	18.0%	-14.13%	1.88%
TOTAL ASSETS
Total Short-Term Assets	$26.19M	$49.48M	$178.3M
Total Long-Term Assets	$236.8M	$241.6M	$281.4M
Total Assets	$263.0M	$291.1M	$459.7M
YoY Change	-26.23%	-36.67%	3.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.511M	$2.390M	$1.649M
YoY Change	-7.19%	44.89%	3.09%
Accrued Expenses			$0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$460.1K
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.700M	$2.578M	$5.860M
YoY Change	-12.02%	-56.01%	-23.89%
LONG-TERM LIABILITIES
Long-Term Debt	$73.56M	$73.48M	$73.12M
YoY Change	0.49%	0.49%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$73.56M	$73.48M	$73.12M
YoY Change	0.49%	0.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.700M	$2.578M	$5.860M
Total Long-Term Liabilities	$73.56M	$73.48M	$73.12M
Total Liabilities	$76.26M	$76.05M	$78.98M
YoY Change	-0.01%	-3.7%	925.69%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$254.0K	$283.4K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$186.7M	$215.0M	$380.7M
YoY Change
Total Liabilities & Shareholders Equity	$263.0M	$291.1M	$459.7M
YoY Change	-26.23%	-36.67%	3.6%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$15.62M	$4.617M	$20.46M
YoY Change	-83.44%	-77.43%	-81.06%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$10.07M	$8.104M	-$1.386M
YoY Change	5.34%	-684.77%	-101.07%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid		$107.8K	$23.08M
YoY Change		-99.53%
Common Stock Issuance & Retirement, Net			-$1.130M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-13.50M	-$107.8K	-24.21M
YoY Change	31.14%	-99.55%	149.61%
NET CHANGE
Cash From Operating Activities	-10.07M	$8.104M	-1.386M
Cash From Investing Activities
Cash From Financing Activities	-13.50M	-$107.8K	-24.21M
Net Change In Cash	-23.57M	$7.996M	-25.60M
YoY Change	18.72%	-131.24%	-121.35%
FREE CASH FLOW
Cash From Operating Activities	-$10.07M	$8.104M	-$1.386M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001509470
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	SSSS	Investment Company Dividend Declared InvestmentCompanyDividendDeclared		usd
CY2023Q1	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution		usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues		shares
CY2023Q1	SSSS	Stock Repurchased For Capital Share Activity StockRepurchasedForCapitalShareActivity		shares
CY2022Q1	SSSS	Accrued Interest On Us Treasury Bills AccruedInterestOnUSTreasuryBills		usd
CY2022Q1	SSSS	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments		usd
CY2022Q1	SSSS	Purchases Of Us Treasury Bills Investments PurchasesOfUSTreasuryBillsInvestments		usd
CY2022Q1	SSSS	Proceeds From Sales Or Maturity Of Investments Us Treasury Bills ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills		usd
CY2023Q1	SSSS	Increase Decrease In Proceeds Receivable IncreaseDecreaseInProceedsReceivable		usd
CY2023Q1	SSSS	Increase Decrease In Payable For Securities Purchased IncreaseDecreaseInPayableForSecuritiesPurchased		usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023Q1	SSSS	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Exercises And Conversions FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisExercisesAndConversions		usd
CY2023Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare
CY2023Q1	SSSS	Investment Company Issuance Offering Per Share InvestmentCompanyIssuanceOfferingPerShare
CY2023Q1	SSSS	Investment Company Repurchase Per Share InvestmentCompanyRepurchasePerShare
CY2022Q1	SSSS	Investment Company Turnover Ratio After Incentive Allocation InvestmentCompanyTurnoverRatioAfterIncentiveAllocation		pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	814-00852
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	SuRo Capital Corp.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-4443543
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	640 Fifth Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10019
CY2023Q1	dei	City Area Code CityAreaCode	(212)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	931-6331
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25338580	shares
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	165088040	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	157188578	usd
CY2023Q1	SSSS	Investments In U.S.Treasury Bills Cost InvestmentsInU.s.TreasuryBillsCost	75986912	usd
CY2022Q4	SSSS	Investments In U.S.Treasury Bills Cost InvestmentsInU.s.TreasuryBillsCost	85056817	usd
CY2023Q1	us-gaap	Investments Investments	241074952	usd
CY2022Q4	us-gaap	Investments Investments	242245395	usd
CY2023Q1	us-gaap	Cash Cash	48113676	usd
CY2022Q4	us-gaap	Cash Cash	40117598	usd
CY2023Q1	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	609685	usd
CY2022Q4	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	628332	usd
CY2023Q1	SSSS	Interest And Dividends Receivable InterestAndDividendsReceivable	105008	usd
CY2022Q4	SSSS	Interest And Dividends Receivable InterestAndDividendsReceivable	138766	usd
CY2023Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	539120	usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	555761	usd
CY2023Q1	us-gaap	Assets Assets	291096643	usd
CY2022Q4	us-gaap	Assets Assets	284412858	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	188357	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	296170	usd
CY2023Q1	us-gaap	Liabilities Liabilities	76053574	usd
CY2022Q4	us-gaap	Liabilities Liabilities	74392156	usd
CY2023Q1	us-gaap	Assets Net AssetsNet	215043069	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	210020702	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28338580	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28338580	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28429499	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28429499	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	283386	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	284295	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	331306021	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	330899254	usd
CY2023Q1	SSSS	Accumulated Net Investment Loss AccumulatedNetInvestmentLoss	-69054370	usd
CY2022Q4	SSSS	Accumulated Net Investment Loss AccumulatedNetInvestmentLoss	-64832605	usd
CY2023Q1	SSSS	Accumulated Net Realized Gain On Investments Net Of Distributions AccumulatedNetRealizedGainOnInvestmentsNetOfDistributions	2741808	usd
CY2022Q4	SSSS	Accumulated Net Realized Gain On Investments Net Of Distributions AccumulatedNetRealizedGainOnInvestmentsNetOfDistributions	2552465	usd
CY2023Q1	SSSS	Accumulated Net Unrealized Depreciation Appreciation Of Investments AccumulatedNetUnrealizedDepreciationAppreciationOfInvestments	-50233776	usd
CY2022Q4	SSSS	Accumulated Net Unrealized Depreciation Appreciation Of Investments AccumulatedNetUnrealizedDepreciationAppreciationOfInvestments	-58882707	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	215043069	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	210020702	usd
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.59
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.39
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0600	pure
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0653	pure
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	75000000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0600	pure
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0653	pure
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	75000000	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	1299082	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	583100	usd
CY2023Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	2136754	usd
CY2022Q1	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1860702	usd
CY2023Q1	SSSS	Directors Fees DirectorsFees	160565	usd
CY2022Q1	SSSS	Directors Fees DirectorsFees	160565	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	990834	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	1272713	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1213286	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	1200786	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	529780	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2050	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	489628	usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses	310989	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5520847	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4807805	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	-4221765	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	-4224705	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	189343	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	3096275	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	8648931	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	21584885	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4616509	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	20456455	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.66
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28378529	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31228046	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28378529	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31228046	shares
CY2022Q4	us-gaap	Assets Net AssetsNet	210020702	usd
CY2021Q4	us-gaap	Assets Net AssetsNet	364846624	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	-4221765	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	-4224705	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	189343	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	3096275	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	8648931	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	21584885	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4616509	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	20456455	usd
CY2022Q1	SSSS	Investment Company Dividend Declared InvestmentCompanyDividendDeclared	3441825	usd
CY2022Q1	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	3441825	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	229896	usd
CY2023Q1	SSSS	Stock Issued During Period Values Share Based Compensation Gross StockIssuedDuringPeriodValuesShareBasedCompensationGross	405858	usd
CY2022Q1	SSSS	Stock Issued During Period Values Share Based Compensation Gross StockIssuedDuringPeriodValuesShareBasedCompensationGross	-30016	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1359607	usd
CY2023Q1	SSSS	Investment Company Capital Share Transactions InvestmentCompanyCapitalShareTransactions	405858	usd
CY2022Q1	SSSS	Investment Company Capital Share Transactions InvestmentCompanyCapitalShareTransactions	-1159727	usd
CY2023Q1	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	5022367	usd
CY2022Q1	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	15854903	usd
CY2023Q1	us-gaap	Assets Net AssetsNet	215043069	usd
CY2022Q1	us-gaap	Assets Net AssetsNet	380701527	usd
CY2022Q4	us-gaap	Shares Outstanding SharesOutstanding	28429499	shares
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	31118556	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	17807	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	90919	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	181597	shares
CY2022Q1	SSSS	Stock Repurchased For Capital Share Activity StockRepurchasedForCapitalShareActivity	-153517	shares
CY2023Q1	us-gaap	Shares Outstanding SharesOutstanding	28338580	shares
CY2022Q1	us-gaap	Shares Outstanding SharesOutstanding	31164443	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4616509	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	20456455	usd
CY2023Q1	SSSS	Realized Investment Gain Losses RealizedInvestmentGainLosses	189343	usd
CY2022Q1	SSSS	Realized Investment Gain Losses RealizedInvestmentGainLosses	3096275	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	8648931	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	21584885	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	104936	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	104940	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	405858	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-30016	usd
CY2023Q1	SSSS	Purchases Of Us Treasury Bills Investments PurchasesOfUSTreasuryBillsInvestments	35497676	usd
CY2023Q1	SSSS	Adjustments To Escrow Proceeds Receivable AdjustmentsToEscrowProceedsReceivable	108394	usd
CY2022Q1	SSSS	Adjustments To Escrow Proceeds Receivable AdjustmentsToEscrowProceedsReceivable	2751610	usd
CY2023Q1	SSSS	Accrued Interest On Us Treasury Bills AccruedInterestOnUSTreasuryBills	458580	usd
CY2023Q1	SSSS	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	2003698	usd
CY2023Q1	SSSS	Proceeds From Sales Or Maturity Of Investments Portfolio Investments ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments	2860159	usd
CY2022Q1	SSSS	Proceeds From Sales Or Maturity Of Investments Portfolio Investments ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments	1287722	usd
CY2023Q1	SSSS	Proceeds From Sales Or Maturity Of Investments Us Treasury Bills ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills	45000118	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-72804	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-147773	usd
CY2023Q1	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-33758	usd
CY2022Q1	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	4160	usd
CY2022Q1	SSSS	Increase Decrease In Proceeds Receivable IncreaseDecreaseInProceedsReceivable	-52493	usd
CY2023Q1	SSSS	Increase Decrease In Escrow Proceeds Receivable IncreaseDecreaseInEscrowProceedsReceivable	-18647	usd
CY2022Q1	SSSS	Increase Decrease In Escrow Proceeds Receivable IncreaseDecreaseInEscrowProceedsReceivable	2530873	usd
CY2022Q1	SSSS	Increase Decrease In Payable For Securities Purchased IncreaseDecreaseInPayableForSecuritiesPurchased	460048	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1680946	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	774341	usd
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-175000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8103901	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1385827	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	229896	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1359607	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	107823	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	23080859	usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1540	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-107823	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24212110	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7996078	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25597937	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	40117598	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	198437078	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	48113676	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	172839141	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1125000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1287500	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4314	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2050	usd
CY2023Q1	SSSS	Capital Commitment CapitalCommitment	1300000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80A_eus-gaap--NatureOfOperations_zN0ibS10dlqg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1—<span id="xdx_826_z4mTUV7IG4Hd">NATURE OF OPERATIONS</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SuRo Capital Corp. (“we”, “us”, “our”, “Company” or “SuRo Capital”), formerly known as Sutter Rock Capital Corp. and as GSV Capital Corp. and formed in September 2010 as a Maryland corporation, is an internally-managed, non-diversified closed-end management investment company. The Company has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), and has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s date of inception was January 6, 2011, which is the date we commenced development stage activities. The Company’s common stock is currently listed on the Nasdaq Global Select Market under the symbol “SSSS” (formerly “GSVC”). Prior to November 24, 2021, our common stock traded on the Nasdaq Capital Market under the same symbol (“SSSS”). The Company began its investment operations during the second quarter of 2011.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below displays the Company’s subsidiaries as of March 31, 2023, which, other than GSV Capital Lending, LLC (“GCL”) and SuRo Capital Sports, LLC, are collectively referred to as the “Taxable Subsidiaries.” The Taxable Subsidiaries were formed to hold certain portfolio investments. The Taxable Subsidiaries, including their associated portfolio investments, are consolidated with the Company for accounting purposes, but have elected to be treated as separate entities for U.S. federal income tax purposes. GCL was formed to originate portfolio loan investments within the state of California and is consolidated with the Company for accounting purposes. Refer to “Note 2—Significant Accounting Policies—<i>Basis of Consolidation</i>” below for further detail.</span></p> <p id="xdx_896_ecustom--ScheduleOfSubsidiariesOfCompanyTableTextBlock_zWNcPb4NE788" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"><span id="xdx_8B6_zWYPpPC1QY1l">SCHEDULE OF COMPANY’S SUBSIDIARIES</span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Subsidiary</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jurisdiction of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Formation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Owned</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">GCL</td><td style="width: 2%"> </td> <td id="xdx_985_edei--EntityIncorporationStateCountryCode_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zFJkjMVpdK48" style="width: 14%; text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td style="width: 2%"> </td> <td id="xdx_989_edei--EntityIncorporationDateOfIncorporation_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zh8aIixkmnvj" style="width: 16%; text-align: center" title="Formation Date">April 13, 2012</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zuJDkJiSbLl7" style="width: 16%; text-align: right" title="Percentage Owned">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">SuRo Capital Sports, LLC (“SuRo Sports”)</td><td> </td> <td id="xdx_988_edei--EntityIncorporationStateCountryCode_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zpvtMZ1dqveb" style="text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td> </td> <td id="xdx_98E_edei--EntityIncorporationDateOfIncorporation_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_z8ztVL6KLC91" style="text-align: center" title="Formation Date">March 19, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zYWWTx0VKL47" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Subsidiaries below are referred to collectively, as the “Taxable Subsidiaries”</td><td> </td> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">GSVC AE Holdings, Inc. (“GAE”)</td><td> </td> <td id="xdx_987_edei--EntityIncorporationStateCountryCode_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zJZMBuZuo2He" style="text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td> </td> <td id="xdx_983_edei--EntityIncorporationDateOfIncorporation_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zOQ15h7WVwOd" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zvEvrN9iOt01" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GSVC AV Holdings, Inc. (“GAV”)</td><td> </td> <td id="xdx_982_edei--EntityIncorporationStateCountryCode_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zKRs2sygJ3lk" style="text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td> </td> <td id="xdx_98C_edei--EntityIncorporationDateOfIncorporation_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z2WJ5hs8Zo88" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zwQRkbiF6QOg" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">GSVC SW Holdings, Inc. (“GSW”)</td><td> </td> <td id="xdx_980_edei--EntityIncorporationStateCountryCode_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zxjnrZaKYjgi" style="text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td> </td> <td id="xdx_988_edei--EntityIncorporationDateOfIncorporation_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zRVt0Z38Juyi" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zTXzfh1PVwse" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GSVC SVDS Holdings, Inc. (“SVDS”)</td><td> </td> <td id="xdx_98A_edei--EntityIncorporationStateCountryCode_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zJUHM0Kka9tk" style="text-align: center" title="Jurisdiction of Incorporation">Delaware</td><td> </td> <td id="xdx_981_edei--EntityIncorporationDateOfIncorporation_c20230101__20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zV5JFksVSrPl" style="text-align: center" title="Formation Date">August 13, 2013</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_znVCsdkfOTh9" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8AE_zCSwFL4Vwabg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s investment objective is to maximize its portfolio’s total return, principally by seeking capital gains on its equity and equity-related investments, and to a lesser extent, income from debt investments. The Company invests principally in the equity securities of what it believes to be rapidly growing venture-capital-backed emerging companies. The Company may invest in these portfolio companies through offerings of the prospective portfolio companies, transactions on secondary marketplaces for private companies, or negotiations with selling stockholders. In addition, the Company may invest in private credit and in founders equity, founders warrants, forward purchase agreements, and private investment in public equity transactions of special purpose acquisition companies. The Company may also invest on an opportunistic basis in select publicly traded equity securities or certain non-U.S. companies that otherwise meet its investment criteria, subject to any applicable limitations under the 1940 Act.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>SURO CAPITAL CORP. AND SUBSIDIARIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>March 31, 2023</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zog9TK3KfVKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zNvlFyZ4dNjl">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in accordance with GAAP requires the Company’s management to make a number of significant estimates. These include estimates of the fair value of certain assets and liabilities and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of certain revenues and expenses during the reporting period. It is likely that changes in these estimates may occur in the near term. The Company’s estimates are inherently subjective in nature and actual results could differ materially from such estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q1	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	609685	usd
CY2022Q4	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	628332	usd
CY2023Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	539120	usd
CY2022Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	555761	usd
CY2019Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2023Q1	us-gaap	Escrow Deposit EscrowDeposit	0	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	0	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	8742396	usd
CY2023Q1	SSSS	Number Of Positions NumberOfPositions	64
CY2023Q1	SSSS	Number Of Portfolio Companies NumberOfPortfolioCompanies	37
CY2022Q4	SSSS	Number Of Positions NumberOfPositions	64
CY2022Q4	SSSS	Number Of Portfolio Companies NumberOfPortfolioCompanies	39
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	165088040	usd
CY2023Q1	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2023Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.768	pure
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	157188578	usd
CY2022Q4	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2022Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.748	pure
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	165088040	usd
CY2022Q4	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2023Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.768	pure
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	157188578	usd
CY2022Q4	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2022Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.748	pure
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	241074952	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	242245395	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	143865093	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	2003698	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-250000	usd
CY2023Q1	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	1330000	usd
CY2023Q1	SSSS	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss	6604361	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	153553152	usd
CY2023Q1	SSSS	Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci	6602698	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	214632504	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	214632504	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	22780064	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-1874470	usd
CY2022	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	90586	usd
CY2022	SSSS	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss	-83021195	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	143865093	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	143865093	usd
CY2022	SSSS	Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci	-70818192	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2022Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	153517	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4616509	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	20456455	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28378529	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31228046	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2023Q1	SSSS	Income Loss From Continuing Operations Diluted IncomeLossFromContinuingOperationsDiluted	4616509	usd
CY2022Q1	SSSS	Income Loss From Continuing Operations Diluted IncomeLossFromContinuingOperationsDiluted	20456455	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28378529	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31228046	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.66
CY2023Q1	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2024-07-31
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	252135	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	288268	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	16574	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	16574	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	48723	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	47332	usd
CY2023Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y3M18D
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0300	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	143883	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	113603	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	257486	usd
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.39
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3947	pure
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0186	pure
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1155000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.57
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	11.72
CY2023Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.15
CY2022Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.14
CY2023Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.01
CY2022Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.10
CY2023Q1	SSSS	Investment Company Unrealized Investment Income Loss From Operations Per Share InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare	0.30
CY2022Q1	SSSS	Investment Company Unrealized Investment Income Loss From Operations Per Share InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare	0.69
CY2022Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	-0.11
CY2022Q1	SSSS	Investment Company Issuance Offering Per Share InvestmentCompanyIssuanceOfferingPerShare	0.01
CY2022Q1	SSSS	Investment Company Repurchase Per Share InvestmentCompanyRepurchasePerShare	-0.06
CY2023Q1	SSSS	Investment Company Share Based Compensation Arrangement By Share Based Payment InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment	0.04
CY2022Q1	SSSS	Investment Company Share Based Compensation Arrangement By Share Based Payment InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment	0.01
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.59
CY2022Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	12.22
CY2023Q1	SSSS	Market Value Value Per Share MarketValueValuePerShare	3.62
CY2022Q1	SSSS	Market Value Value Per Share MarketValueValuePerShare	8.63
CY2023Q1	SSSS	Investment Company Total Return Basedon Market Value InvestmentCompanyTotalReturnBasedonMarketValue	-0.0474	pure
CY2022Q1	SSSS	Investment Company Total Return Basedon Market Value InvestmentCompanyTotalReturnBasedonMarketValue	-0.3172	pure
CY2023Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0271	pure
CY2022Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0503	pure
CY2023Q1	us-gaap	Shares Outstanding SharesOutstanding	28338580	shares
CY2022Q1	us-gaap	Shares Outstanding SharesOutstanding	31164443	shares
CY2023Q1	us-gaap	Assets Net AssetsNet	215043069	usd
CY2022Q1	us-gaap	Assets Net AssetsNet	380701527	usd
CY2023Q1	SSSS	Average Net Asset AverageNetAsset	209347362	usd
CY2022Q1	SSSS	Average Net Asset AverageNetAsset	364015960	usd
CY2023Q1	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.1070	pure
CY2022Q1	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0539	pure
CY2023Q1	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0818	pure
CY2022Q1	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0473	pure
CY2023Q1	SSSS	Investment Company Turnover Ratio After Incentive Allocation InvestmentCompanyTurnoverRatioAfterIncentiveAllocation	0.0124	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.04	pure
CY2023Q1	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	(1) 98% of our ordinary income (taking into account certain deferrals and elections) for each calendar year, (2) 98.2% of our capital gain net income (adjusted for certain ordinary losses) for the 1-year period ending October 31 of each such calendar year and (3) any ordinary income and net capital gains for preceding years, but not distributed during such years and on which the Company paid no U.S. federal income tax
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.04	pure
CY2019Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.57
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.57
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	2.57
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	2.57
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	3000000	shares
CY2023Q1	us-gaap	Share Price SharePrice	0.10
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.57
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	385000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.57
CY2019Q4	SSSS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Exercisable Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExercisableWeightedAverageGrantDateFairValue	2.57
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1155000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1155000	shares
CY2023Q1	us-gaap	Stock Repurchase Program Expiration Date StockRepurchaseProgramExpirationDate	2023-04-17
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3000000	shares
CY2023Q1	SSSS	Percentage Of Outstanding Shares PercentageOfOutstandingShares	0.106	pure

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
ssss-20230331_cal.xml	Edgar Link	unprocessable
ssss-20230331_def.xml	Edgar Link	unprocessable
0001493152-23-016116-index-headers.html	Edgar Link	pending
0001493152-23-016116-index.html	Edgar Link	pending
0001493152-23-016116.txt	Edgar Link	pending
0001493152-23-016116-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssss-20230331.xsd	Edgar Link	pending
ssss-20230331_lab.xml	Edgar Link	unprocessable
ssss-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSSS
SURO CAPITAL CORP. Stock $ssss

2023 Q2 Form 10-Q Financial Statement

#000149315223016116 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSSS SURO CAPITAL CORP. Stock $ssss

2023 Q2 Form 10-Q Financial Statement

#000149315223016116 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSSS
SURO CAPITAL CORP. Stock $ssss